Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05424042 · ClinicalTrials.gov registry record · NA
Health, Aging and Later-Life Outcomes
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT05424042: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT05424042 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05424042, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this pilot research is to test the feasibility of two interventions focused on either reducing total calorie intake or reducing the total time that calories are ingested each day in older adults. Participation in this research will involve visits to our clinic for testing and weekly intervention visits (in-person or remote depending on group assignment) for nine months with total participation lasting about a year.
Primary Outcome
Ability of participants to sustain Caloric Restriction \>10%
Interventions
- BEHAVIORAL In-Person Caloric Restriction
- BEHAVIORAL Remote Caloric Restriction
- BEHAVIORAL Time-restricted
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2024-07-22 |
| Phase | NA |
What the finished NCT05424042 record still lists
NCT05424042 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which In-Person Caloric Restriction is the first listed.
NCT05424042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05424042 about?
NCT05424042 is a clinical study titled "Health, Aging and Later-Life Outcomes". The purpose of this pilot research is to test the feasibility of two interventions focused on either reducing total calorie intake or reducing the total time that calories are ingested each day in older adults. Participation in this research will involve visits to our clinic for testing and weekly i...
What is the current status of trial NCT05424042?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2022-07-05. Estimated completion is 2024-07-22.
What interventions are being tested in trial NCT05424042?
The interventions under investigation include: In-Person Caloric Restriction (BEHAVIORAL), Remote Caloric Restriction (BEHAVIORAL), Time-restricted (BEHAVIORAL).
Who is sponsoring clinical trial NCT05424042?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05424042's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI